Page last updated: 2024-11-07

3-methylhippuric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-methylhippuric acid, also known as 3-methylbenzoylglycine, is a naturally occurring compound found in the urine of mammals. It is a metabolic product of toluene, a common industrial solvent. The synthesis of 3-methylhippuric acid involves the conjugation of toluene with glycine in the liver. This compound is studied as a biomarker for toluene exposure and is used to assess the levels of toluene exposure in workers. 3-methylhippuric acid levels in urine can be elevated in individuals exposed to toluene through inhalation, ingestion, or skin contact. Studies have shown that exposure to toluene can have adverse health effects, including neurotoxicity, reproductive toxicity, and liver damage. However, 3-methylhippuric acid itself is not considered to be toxic.'

3-methylhippuric acid: urinary metabolite of m-xylene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

m-methylhippuric acid : An N-acylglycine that is the 3-methyl derivative of hippuric acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID99223
CHEMBL ID456202
CHEBI ID68500
SCHEMBL ID1285808
MeSH IDM0098726

Synonyms (52)

Synonym
27115-49-7
m-methylhippuric acid
m-toluric acid
glycine, n-(3-methylbenzoyl)-
3-methylbenzoylglycine
n-(3-methylbenzoyl)glycine
nsc201735
nsc-201735
hippuric acid, m-methyl-
OPREA1_856142
3-methylhippuric acid, 98%
MAYBRIDGE1_006562
inchi=1/c10h11no3/c1-7-3-2-4-8(5-7)10(14)11-6-9(12)13/h2-5h,6h2,1h3,(h,11,14)(h,12,13
3-methylhippuric acid
M-3780
AKOS000264625
HMS560C06
2-[(3-methylbenzoyl)amino]acetic acid
m-toluric acid-d7
n-(m-toluoyl)glycine
T0312
chebi:68500 ,
CHEMBL456202
STL140665
n-[(3-methylphenyl)carbonyl]glycine
nsc 201735
unii-w60w59c1g5
meta-methylhippuric acid
w60w59c1g5 ,
3-methyl hippuric acid
FT-0638674
SCHEMBL1285808
3-methylhippuricacid
[(3-methylbenzoyl)amino]acetic acid #
DTXSID90181579
2-[(3-methylphenyl)formamido]acetic acid
mfcd00044399
Z56827661
3_methylhippuricacid
hippuric acid, 3-methyl-
toluric acid, m-
2-(3-methylbenzamido)acetic acid
glycine,n-(3-methylbenzoyl)-
Q22132798
2-(3-methylbenzamido)aceticacid
vzy ,
n-(3-methylbenzene-1-carbonyl)glycine
A877026
D85923
CS-0137677
EN300-16947
SY051315

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"A physiologically based pharmacokinetic model of the transfer of organic solvents in rat bodies was developed."( Development of a physiologically based pharmacokinetic model of organic solvent in rats.
Horiuchi, J; Kaneko, T; Sato, A, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
N-acylglycineAn N-acyl-amino acid in which amino acid specified is glycine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID388274Ratio of Vm(app) to Km(app) for rat recombinant peptidylglycine alpha-amidating monooxygenase relative to hippuric acid2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID388272Activity of rat recombinant peptidylglycine alpha-amidating monooxygenase assessed as stimulation of oxygen consumption2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID388273Ratio of Vm(app) to Km(app) for rat recombinant peptidylglycine alpha-amidating monooxygenase2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (48.15)18.7374
1990's9 (33.33)18.2507
2000's3 (11.11)29.6817
2010's1 (3.70)24.3611
2020's1 (3.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.29 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]